# Circularis Biotechnologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/circularis-biotechnologies

- Industry: Biotechnology
- Headquarters: Oakland, US
- Website: www.circularisbiotech.com
- Latest round: Seed (Apr 9, 2020)
- Investors on record: 5

## About

Circularis Biotechnologies, Inc. develops biotechnology solutions for enhancing drug discovery and bioproduction, specializing in genetic medicines and custom biocatalysis services.Circularis Biotechnologies, Inc. specializes in innovative biotechnological solutions. Founded in 2014 in Oakland, US, the company was established by LeAnn Lindsay and Paul Feldstein. Mat Falkowski serves as the CEO. In October 2022, Circularis was acquired by Ginkgo Bioworks, Inc. from various investors including Alix Ventures and IndieBio. The company has been involved in 3 total deals, with the most recent deal occurring in October 2022.Circularis Biotechnologies, Inc. focuses on biotechnological solutions tailored for agriculture, biopharma, and industrial applications. Their offerings include genetic medicines and customizable biocatalysis solutions, designed to enhance drug discovery and optimize various production processes for a diverse clientele including pharmaceutical companies and agricultural firms across North America, Europe, and Asia.Circularis Biotechnologies generates revenue through direct collaborations and partnerships with clients, often involving custom enzyme development and gene editing services. The company also utilizes subscription models for proprietary data and analytics services, although specific pricing structures are not disclosed.Looking ahead, Circularis Biotechnologies aims to develop new products focused on RNA therapeutics and cell therapy, leveraging recent funding from their acquisition by Ginkgo BioWorks to facilitate these innovations. The company plans to expand its market reach primarily into Europe and Asia by 2025, enhancing its service offerings in bioproduction and gene therapy.

## Funding rounds

- Seed, Apr 9, 2020 — SOSV, IndieBio, Cantos Ventures, KdT Ventures
- Seed, Mar 1, 2020 — Alix Ventures

## Investors

- Alix Ventures (https://capitalatlas.ai/funds/alix-ventures) — Seed
- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- IndieBio (https://capitalatlas.ai/funds/indiebio) — Seed
- Cantos Ventures (https://capitalatlas.ai/funds/cantos-ventures) — Seed
- KdT Ventures (https://capitalatlas.ai/funds/kdt-ventures) — Seed